Marvel Studios president Kevin Feige and producer Amy Pascal recently suggested a potential meeting between Tom Holland's Spider-Man and Tom Hardy's Venom. Speaking on the Happy Sad Confused podcast, both executives expressed hope for the crossover.
"Always have hope": The cryptic podcast exchange between Feige and Pascal
During a recent appearance on the Happy Sad Confused podcast, host Josh Horowitz pressed Kevin Feige on whether Tom Hardy's Venom would eventually cross paths with Tom Holland's Spider-Man. rather than providing a definitive confirmation, Feige responded with the enigmatic phrase, "Always have hope," according to the report .
Producer Amy Pascal echoed this sentiment,stating, "I have hope. We have hope." While these comments stop short of an official announcement, the coordinated optimism from the two most powerful figures in the Spider-Man cinematic ecosystem suggests that the narrative groundwork is being actively discussed behind the scenes at Marvel Studios and Sony.
From No Way Home to Let There Be Carnage: The symbiote's breadcrumbs
The possibility of a crossover is not a new theory, as the films have spent years planting evidence of a shared multiverse. As the source notes, the post-credits sequence of Venom: Let There Be Carnage featured Eddie Brock and his symbiote viewing a television broadcast of Tom Holland's Spider-Man,effectively bridging the gap between their separate cinematic worlds.
This connection was further cemented in the finale of Spider-Man: No Way Home, where Tom Hardy's character was briefly transported into the MCU via a spell cast by Doctor Strange. although the character was returned to his original universe, a small fragment of the black symbiote remained behind in the MCU, providing a tangible plot device for future writers to exploit.
July 31, 2026: Will Spider-Man: Brand New Day be the catalyst?
Attention now turns to the next scheduled installment, Spider-Man: Brand New Day, which is set for release on July 31, 2026. Directed by Destin Daniel Cretton, this film is expected to pivot the character of Peter Parker in a new direction, and the lingering symbiote trace could serve as the primary engine for the plot.
Tom Holland has previously expressed his own enthusiasm for the pairing, noting in past interviews that he would welcome the inclusion of Venom in his films.. The pairing of Peter Parker's youthful energy with the brooding, chaotic nature of Venom offers a comedic and dramatic contrast that Marvel Studios has historically leveraged for success.
The Sony and Marvel Studios rights tangle
The primary obstacle to a full-scale team-up remains the complex legal arrangement between Sony and Marvel Studios. While the two entities have collaborated successfully on the Homecoming trilogy and the multiverse-spanning No Way Home, the specific rights to the Venom character reside with Sony, making any crossover a matter of corporate negotiation as much as creative vision.
Several key questions remain unanswered: will Venom appear as a full-fledged antagonist or an unlikely ally in Spider-Man: Brand New Day? Furthermore, it remains unclear if Tom Hardy will return in a leading capacity or if the symbiote will simply be transferred to a new host within the MCU. The rpeort provides no confirmation on the script's status, leaving fans to rely on the "hope" expressed by Feige and Pascal.
Comments 0